Virtual Support Platform (HERCaRE Application) for the Improvement of Survivorship Among Black Breast Cancer Survivors

NCT07126522 | Completed

• 2 other identifiers: 25-001524NCI-2025-05318
• Study Type: interventional
• Target: 45
• Locations: 1 country
• Sites: 1

Brief Summary

This clinical trial studies how well a virtual support platform, the Health Equity Resources for Breast Cancer Responsive Education (HERCaRE) application (app), works in improving survivorship among Black survivors of breast cancer. The HERCaRE platform is a mobile-friendly app that includes culturally tailored educational materials, interactive content, and health equity resources to help patients better understand and manage survivorship after breast cancer treatment. This trial may help improve how digital health interventions can enhance survivorship support and access to resources.

Conditions

Breast Carcinoma

Outcome Measures

Primary Outcomes (4)

• Survivorship engagement - login

  Assessed by active use of the Health Equity Resources for Breast Cancer Responsive Education (HERCaRE) platform, defined as number of logins per participant.

  Up to 6 weeks

• Survivorship engagement - time

  Assessed by the length of time each participant spent using the HERCaRE platform.

  Up to 6 weeks

• Survivorship engagement - self-report

  Assessed by self-reported actions such as initiating conversations with providers or accessing survivorship resources. Information will be obtained through semi-structured interviews.

  Up to 6 weeks

• Adherence to follow-up care

  Assessed by participant self-reported scheduling or completion of appointments (e.g., mammograms, primary care physician visits). Information will be obtained through semi-structured interviews.

  Up to 6 weeks

Secondary Outcomes (2)

• Participant satisfaction - HERCaRE Final Survey

  Up to 6 weeks

• Perceived usability - HERCaRE Final Survey

  Up to 6 weeks

Study Arms (1)

Supportive Care (HERCaRE app)

EXPERIMENTAL

Patients use the HERCaRE app over 4-6 weeks on study.

Other: Discussion; Other: Internet-Based Intervention; Other: Interview; Other: Survey Administration

Interventions

Discussion OTHER

Ancillary studies

Also known as: Discuss

Supportive Care (HERCaRE app)

Internet-Based Intervention OTHER

Use the HERCaRE app

Supportive Care (HERCaRE app)

Interview OTHER

Ancillary studies

Supportive Care (HERCaRE app)

Survey Administration OTHER

Ancillary studies

Supportive Care (HERCaRE app)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adults aged 18 and older
• Self-identified Black women with a history of breast cancer
• "Self-identified Black woman" refers to individuals who personally identify as a Black or African American woman, inclusive of cisgender women from diverse cultural backgrounds. This will be confirmed during a verbal eligibility screening conducted prior to enrollment
• Completed active breast cancer treatment (e.g., surgery, chemotherapy, or radiation) at least one month prior to enrollment; survivors receiving long-term hormonal therapy are also eligible
• Reside within the Mayo Clinic Florida catchment area
• Have access to a smartphone or willingness to use alternative access points
• "Alternative access points" refer to non-clinical settings through which participants may be made aware of the study, including support groups, community health events, churches, and partner organizations that engage with breast cancer survivors outside of the traditional healthcare setting

You may not qualify if:

• Individuals without a history of breast cancer
• Those unable to provide verbal consent
• Individuals who lack the ability to engage with digital platforms, as determined during the screening process via brief questions assessing comfort and experience with mobile technology. Participants must be able to open the app, read content, and complete survey independently. iPads will be available for participants who do not have their own mobile device

Sponsors & Collaborators

• Mayo Clinic: lead

Study Sites (1)

Mayo Clinic in Florida

Jacksonville, Florida, 32224-9980, United States

Location

Related Links

• Mayo Clinic Clinical Trials

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Interviews as Topic

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Manisha Salinas, DrPH

  Mayo Clinic

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 11, 2025
• First Posted: August 17, 2025
• Study Start: July 18, 2025
• Primary Completion: March 2, 2026
• Study Completion: March 2, 2026
• Last Updated: March 30, 2026

Record last verified: 2026-03

Locations

US (1)